TÜV NORD GROUP
Evangelos Magnisalis is a seasoned professional in the field of bioengineering and medical devices, currently serving as Lead Auditor and Expert on Medical Devices at TÜV Hellas & TÜV Nord Cert of the TÜV NORD GROUP since September 2019. Previously, Evangelos held positions as Staff Research and Test Engineer at DePuy Synthes, and as CEO and Owner of BioHexagon Ltd, which specializes in biomedical studies and research. Earlier experience includes leadership roles at Bioengineering.gr and Ekevyl SA, where expertise was honed in orthopaedic biomechanics and regulatory compliance for medical devices. Evangelos holds a PhD in Bioengineering from the University of Strathclyde and an MSc in Mechanical Engineering from the University of Patras.
This person is not in any offices
TÜV NORD GROUP
With over 10,000 employees in more than 70 countries in Europe, Asia, Africa and the Americas, TÜV NORD GROUP is actively committed to its national and international customers. Its broad consulting, service and inspection portfolio encompasses both specific individual tests and inspections and also management of complex safety solutions. TÜV NORD GROUP is organised into Mobility, Industrial Services, Training, IT, Natural Resources and Aerospace business units – competence centres are in permanent contact with customers for analysing, consulting and also developing and implementing customised solutions. TÜV NORD GROUP customers benefit from the broad, well-founded expertise of qualified and approved consultants and inspectors. Through their understanding of the customer's situation and needs and the technical area concerned, these experts form the backbone of the Group's success.